Results reflect a year of significant change and with the company undergoing a strategic review we look to the future potential rather than historic results as a basis for valuing the company. The company is now on track to reach very high ROE as the three centred strategy is executed. For now we maintain our target price of 39p but once the strategic review is finalised we could see why the shares would trade at 70p.
